Display options
Cite
Wu S, Li XF, Wu YY, et al. . Front Immunol. 2021;12:731842doi: 10.3389/fimmu.2021.731842.
Wu, S., Li, X. F., Wu, Y. Y., Yin, S. Q., Huang, C., & Li, J. (2021). . Frontiers in immunology, 12731842. https://doi.org/10.3389/fimmu.2021.731842
Wu, Sha, et al. "." Frontiers in immunology vol. 12 (2021): 731842. doi: https://doi.org/10.3389/fimmu.2021.731842
Wu S, Li XF, Wu YY, Yin SQ, Huang C, Li J. . Front Immunol. 2021 Sep 24;12:731842. doi: 10.3389/fimmu.2021.731842. eCollection 2021. PMID: 34630412; PMCID: PMC8498590.
Copy Download .nbib Format: NLM
Share it on

Front Immunol. 2021 Sep 24;12:731842. doi: 10.3389/fimmu.2021.731842. eCollection 2021.

[No title available]

Frontiers in immunology

Sha Wu, Xiao-Feng Li, Yuan-Yuan Wu, Su-Qin Yin, Cheng Huang, Jun Li

Affiliations

  1. Anhui Institute of Innovative Drugs, The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, China.
  2. Postdoctoral Station of Clinical Medicine of Anhui Medical University, Hefei, China.

PMID: 34630412 PMCID: PMC8498590 DOI: 10.3389/fimmu.2021.731842

Abstract

Rheumatoid arthritis (RA), one of the most common autoimmune diseases, is characterized by immune cell infiltration, fibroblast-like synovial cell hyperproliferation, and cartilage and bone destruction. To date, numerous studies have demonstrated that immune cells are one of the key targets for the treatment of RA.

Copyright © 2021 Wu, Li, Wu, Yin, Huang and Li.

Keywords: N6-methyladenosine; autoimmune disease; cancers; immune cells; rheumatoid arthritis

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Leuk Lymphoma. 2012 Nov;53(11):2237-44 - PubMed
  2. EMBO J. 2021 Feb 1;40(3):e105977 - PubMed
  3. Mol Biol Rep. 2020 May;47(5):3423-3437 - PubMed
  4. Sci Rep. 2017 Oct 4;7(1):12671 - PubMed
  5. Cell Res. 2017 Sep;27(9):1115-1127 - PubMed
  6. Nat Rev Rheumatol. 2016 Aug;12(8):472-85 - PubMed
  7. Arthritis Rheum. 2002 Jul;46(7):1763-72 - PubMed
  8. Cancer Lett. 2016 Jun 28;376(1):34-42 - PubMed
  9. Cancer Res. 2021 Sep 15;81(18):4778-4793 - PubMed
  10. Mol Cell. 2016 Jul 21;63(2):306-317 - PubMed
  11. Lancet. 1981 Oct 17;2(8251):839-42 - PubMed
  12. Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17278-83 - PubMed
  13. Front Med (Lausanne). 2021 Jul 06;8:607585 - PubMed
  14. PLoS Genet. 2018 May 25;14(5):e1007412 - PubMed
  15. Int J Biochem Cell Biol. 2020 May;122:105731 - PubMed
  16. Open Med (Wars). 2019 Mar 02;14:25-31 - PubMed
  17. Oncol Lett. 2018 Dec;16(6):6966-6970 - PubMed
  18. Cell Res. 2017 Sep;27(9):1100-1114 - PubMed
  19. Mediators Inflamm. 2019 Oct 24;2019:3120391 - PubMed
  20. Semin Immunopathol. 2017 Feb;39(2):153-163 - PubMed
  21. Biomed Res Int. 2020 Aug 20;2020:5735279 - PubMed
  22. Nat Commun. 2019 Jun 25;10(1):2782 - PubMed
  23. Mol Cell Biol. 2007 Apr;27(8):3056-64 - PubMed
  24. Nat Cell Biol. 2018 Sep;20(9):1074-1083 - PubMed
  25. Mol Cell. 2019 May 16;74(4):640-650 - PubMed
  26. Nature. 2017 Dec 7;552(7683):126-131 - PubMed
  27. Cell. 2015 Jun 4;161(6):1388-99 - PubMed
  28. Oncogene. 2019 May;38(19):3667-3680 - PubMed
  29. Gene. 2020 Jan 5;722:144076 - PubMed
  30. Exp Cell Res. 2020 Apr 1;389(1):111894 - PubMed
  31. Nat Chem Biol. 2014 Nov;10(11):927-9 - PubMed
  32. Clin Ther. 2015 Apr 1;37(4):764-82 - PubMed
  33. Cell Res. 2018 Sep;28(9):904-917 - PubMed
  34. Nat Commun. 2016 Aug 25;7:12626 - PubMed
  35. Nat Commun. 2019 Apr 23;10(1):1898 - PubMed
  36. J Cell Mol Med. 2018 May;22(5):2558-2568 - PubMed
  37. Gut. 2020 Jul;69(7):1193-1205 - PubMed
  38. Front Oncol. 2019 Jun 12;9:502 - PubMed
  39. Arthritis Rheum. 1984 Aug;27(8):845-51 - PubMed
  40. Cent Eur J Immunol. 2019;44(3):237-245 - PubMed
  41. Biochem Pharmacol. 2019 Jul;165:152-169 - PubMed
  42. Onco Targets Ther. 2019 Nov 05;12:9143-9152 - PubMed
  43. J Cell Physiol. 2020 Jan;235(1):548-562 - PubMed
  44. Biochem Biophys Res Commun. 2019 May 7;512(3):479-485 - PubMed
  45. PLoS Pathog. 2020 Feb 13;16(2):e1008305 - PubMed
  46. Sci Rep. 2016 Jul 07;6:29338 - PubMed
  47. Proc Natl Acad Sci U S A. 1974 Oct;71(10):3971-5 - PubMed
  48. Nucleic Acids Res. 2017 Jun 2;45(10):6051-6063 - PubMed
  49. PLoS One. 2015 Feb 27;10(2):e0118438 - PubMed
  50. Sci Rep. 2019 Feb 4;9(1):1351 - PubMed
  51. Biochem Biophys Res Commun. 2015 Apr 3;459(2):201-207 - PubMed
  52. Nat Commun. 2018 Nov 14;9(1):4772 - PubMed
  53. Cell Res. 2014 Feb;24(2):177-89 - PubMed
  54. Nature. 2019 Feb;566(7743):270-274 - PubMed
  55. Cancer Lett. 2018 Feb 28;415:11-19 - PubMed
  56. Hepatology. 2018 Jun;67(6):2254-2270 - PubMed
  57. Thorac Cancer. 2015 Jul;6(4):534-8 - PubMed
  58. Cancer Lett. 2019 Feb 1;442:252-261 - PubMed
  59. Arthritis Rheum. 2003 Aug;48(8):2146-54 - PubMed
  60. J Biol Chem. 2021 Sep;297(3):101058 - PubMed
  61. RNA. 1997 Nov;3(11):1233-47 - PubMed
  62. Nat Chem Biol. 2014 Feb;10(2):93-5 - PubMed
  63. Nat Rev Immunol. 2015 Apr;15(4):243-54 - PubMed
  64. Onco Targets Ther. 2019 Aug 06;12:6191-6201 - PubMed
  65. Cell Res. 2017 May;27(5):626-641 - PubMed
  66. J Biol Chem. 2013 Nov 15;288(46):33292-302 - PubMed
  67. J Immunol. 2001 Aug 1;167(3):1758-68 - PubMed
  68. Nucleic Acids Res. 1975 Oct;2(10):1653-68 - PubMed
  69. Nat Chem Biol. 2011 Oct 16;7(12):885-7 - PubMed
  70. Cancer Cell. 2017 Apr 10;31(4):591-606.e6 - PubMed
  71. J Leukoc Biol. 2016 Oct;100(4):823-833 - PubMed
  72. Cell Res. 2014 Dec;24(12):1403-19 - PubMed
  73. Nat Immunol. 2019 Feb;20(2):173-182 - PubMed
  74. Science. 2018 Sep 28;361(6409):1346-1349 - PubMed
  75. Cell Res. 2017 Mar;27(3):315-328 - PubMed
  76. Mol Cancer. 2019 Oct 16;18(1):143 - PubMed
  77. Mol Cell. 2013 Jan 10;49(1):18-29 - PubMed
  78. Mol Cancer. 2019 Aug 22;18(1):127 - PubMed
  79. Ann Hum Genet. 2020 Jan;84(1):72-79 - PubMed
  80. J Cell Mol Med. 2018 Oct;22(10):4630-4639 - PubMed
  81. Mol Cancer. 2019 Mar 28;18(1):46 - PubMed
  82. Nat Commun. 2021 Apr 12;12(1):2183 - PubMed
  83. Int J Mol Sci. 2019 Mar 15;20(6): - PubMed
  84. Mol Med. 2021 Aug 19;27(1):91 - PubMed
  85. Arthritis Rheum. 1991 Sep;34(9):1125-32 - PubMed
  86. Mol Cancer. 2019 Jun 22;18(1):110 - PubMed
  87. Pharmacol Res. 2021 Aug 21;:105845 - PubMed
  88. J Rheumatol. 2000 Feb;27(2):339-46 - PubMed
  89. J Gastroenterol. 2013 Nov;48(11):1271-82 - PubMed
  90. Hepatology. 2017 Feb;65(2):529-543 - PubMed
  91. Sci Rep. 2016 Feb 05;6:20531 - PubMed
  92. Proc Natl Acad Sci U S A. 2016 Apr 5;113(14):E2047-56 - PubMed
  93. J Exp Clin Cancer Res. 2018 Feb 27;37(1):40 - PubMed
  94. Nat Immunol. 2020 May;21(5):501-512 - PubMed
  95. Mol Cancer. 2021 Aug 20;20(1):105 - PubMed
  96. Cancer Biomark. 2018;21(4):859-868 - PubMed
  97. Front Oncol. 2019 May 03;9:332 - PubMed
  98. Front Immunol. 2016 Jan 06;6:620 - PubMed
  99. Cell Stem Cell. 2018 Feb 1;22(2):191-205.e9 - PubMed
  100. Am J Physiol Cell Physiol. 2019 Oct 1;317(4):C762-C775 - PubMed
  101. Cancer Cell Int. 2021 Aug 21;21(1):441 - PubMed
  102. Nature. 2015 Mar 26;519(7544):482-5 - PubMed
  103. Cell Rep. 2017 Mar 14;18(11):2622-2634 - PubMed
  104. Cancer Res. 2021 Aug 6;: - PubMed
  105. Cancer Cell. 2017 Jan 9;31(1):127-141 - PubMed
  106. Am J Transl Res. 2019 Sep 15;11(9):6084-6092 - PubMed
  107. Hum Cell. 2021 Nov;34(6):1697-1708 - PubMed
  108. Proc Natl Acad Sci U S A. 2020 Aug 18;117(33):20159-20170 - PubMed
  109. Mol Ther. 2020 Feb 5;28(2):599-612 - PubMed
  110. Oncol Lett. 2019 Feb;17(2):2473-2478 - PubMed
  111. Mol Cell. 2016 May 5;62(3):335-345 - PubMed
  112. J Physiol Biochem. 2019 Aug;75(3):379-389 - PubMed
  113. Carcinogenesis. 2020 Jul 10;41(5):541-550 - PubMed
  114. Nature. 2014 Jan 2;505(7481):117-20 - PubMed
  115. J Immunol. 1992 Jun 15;148(12):3776-82 - PubMed
  116. Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13028-33 - PubMed
  117. Nature. 2017 Aug 17;548(7667):338-342 - PubMed

Publication Types